OUR COMMITMENT TO INCLUSION AND DIVERSITY
This starts with our mission to leave no person living with HIV behind. That means ensuring we are supporting people living with HIV around the world, no matter their race, sexual orientation, ethnicity, gender or nationality. We do this through our breakthrough innovation, our diverse portfolio of medicines and through the work we do to partner with HIV communities and amplify the voices of people living with HIV.
Inclusion and diversity is at the heart of our culture and how we operate as a company. We strive to bring together talented and diverse people whose unique experience, knowledge and personal perspectives make us stronger as a team and as a business.
We’ ve made good progress – reviewing our recruitment and selection processes, delivering new inclusion training and launching a development programme for ethnically diverse employees, and we want to achieve even more. That is why we are proud to be an important part of the new aspirational targets announced by our majority shareholder, GSK, to ensure we have the focus we need to do even better. This is a significant and visible step in demonstrating our continued commitment to Inclusion and Diversity.
Inclusion & Diversity Commitments
||1. As a member of the Valuable 500, deliver against its objectives
||2. Globally, over 45% female representation in senior roles by end of 2025
|LGBT+||3. Be recognized in global LGBT+ indices|
|Race & Ethnicity||
4. In the US: at least 30% ethnically diverse leaders in our VP and above roles by the end of 2025
5. In the UK: at least 18% ethnically diverse leaders in our VP and above roles by the end of 2025
Click here to find out more about our new aspirations and how we, along with our majority shareholder GSK, are working to foster a more inclusive environment.